
Hancock Jaffe Laboratories, Inc. Retained Earnings 2011-2025 | HJLI
Retained earnings — this is the portion of a company’s net profit that has not been distributed to shareholders as dividends but remains at the company’s disposal for future use. It is also referred to as retained income or accumulated earnings.Possible uses include
- reinvestment in development (R&D, equipment, marketing)
- debt repayment
- acquisition of other companies
- creation of reserves for the future
A high level of retained earnings indicates that the company is in a growth phase, accumulating capital and prioritizing reinvestment over dividend payouts. Conversely, low or negative retained earnings may suggest either a generous dividend policy, in which all profits are distributed to shareholders, or ongoing losses that reduce the overall financial result.
The presence of retained earnings does not indicate that the company has available cash — it is solely an accounting figure reflecting the accumulated portion of net profit remaining after dividends have been paid. Therefore, it is important for investors to analyze not only the amount of retained earnings, but also how effectively it is used to develop the business, reduce debt, or build financial stability.
Annual Retained Earnings Hancock Jaffe Laboratories, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| - | -56.2 M | -48.6 M | -35.5 M | -27.7 M | -24.3 M | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -24.3 M | -56.2 M | -38.5 M |
Retained Earnings of other stocks in the Medical devices industry
| Issuer | Retained Earnings | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Apyx Medical Corporation
APYX
|
-54.4 M | $ 3.86 | -3.26 % | $ 134 M | ||
|
BioSig Technologies
BSGM
|
-255 M | - | 37.08 % | $ 85.7 M | ||
|
Abiomed
ABMD
|
828 M | - | - | $ 17.2 B | ||
|
GenMark Diagnostics, Inc.
GNMK
|
-533 M | - | - | $ 1.77 B | ||
|
Cutera
CUTR
|
-303 M | - | -10.19 % | $ 1.99 M | ||
|
Eargo
EAR
|
-514 M | - | - | $ 10.2 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
-185 M | - | -5.86 % | $ 30.6 M | ||
|
Bio-Rad Laboratories
BIO
|
7.42 B | $ 307.92 | -1.93 % | $ 8.69 B | ||
|
Apollo Endosurgery
APEN
|
-337 M | - | - | $ 475 M | ||
|
Acutus Medical
AFIB
|
-600 M | - | -26.83 % | $ 2.62 M | ||
|
Bruker Corporation
BRKR
|
2.41 B | $ 45.13 | -2.67 % | $ 6.72 K | ||
|
Allied Healthcare Products
AHPI
|
-15.7 M | - | 3.58 % | $ 2.21 M | ||
|
Conformis
CFMS
|
-581 M | - | - | $ 16.4 M | ||
|
Abbott Laboratories
ABT
|
47.3 B | $ 125.1 | 1.48 % | $ 218 B | ||
|
Boston Scientific Corporation
BSX
|
2.67 B | $ 92.34 | 0.64 % | $ 136 B | ||
|
CryoLife, Inc.
CRY
|
20 M | - | -4.14 % | $ 702 M | ||
|
EDAP TMS S.A.
EDAP
|
-82.6 M | $ 2.56 | 8.94 % | $ 95.5 M | ||
|
Invacare Corporation
IVC
|
-78.4 M | - | - | $ 24.7 M | ||
|
Cardiovascular Systems
CSII
|
-424 M | - | 0.15 % | $ 844 M | ||
|
IRIDEX Corporation
IRIX
|
-79 M | $ 0.92 | -4.72 % | $ 14.8 M | ||
|
IRadimed Corporation
IRMD
|
56.8 M | $ 96.35 | -1.06 % | $ 1.22 B | ||
|
OrthoPediatrics Corp.
KIDS
|
-236 M | $ 17.7 | -3.46 % | $ 408 M | ||
|
Soliton, Inc.
SOLY
|
-70.6 M | - | -1.42 % | $ 435 M | ||
|
Itamar Medical Ltd.
ITMR
|
-119 M | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
-39.3 M | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
-395 M | - | - | $ 111 M | ||
|
LivaNova PLC
LIVN
|
-903 M | $ 62.79 | -1.82 % | $ 3.41 B | ||
|
Pulmonx Corporation
LUNG
|
-468 M | $ 2.53 | 0.86 % | $ 99 M | ||
|
Dynatronics Corporation
DYNT
|
-40.5 M | - | 14.99 % | $ 929 K | ||
|
Intersect ENT, Inc.
XENT
|
-303 M | - | - | $ 955 M | ||
|
InMode Ltd.
INMD
|
875 M | $ 14.56 | 0.76 % | $ 1.15 B | ||
|
Cognyte Software Ltd.
CGNT
|
-157 M | $ 9.88 | 0.05 % | $ 709 M | ||
|
Myomo
MYO
|
-88.8 M | $ 1.06 | -1.85 % | $ 7.47 M | ||
|
Second Sight Medical Products
EYES
|
-122 M | - | -0.97 % | $ 54.4 M | ||
|
Integra LifeSciences Holdings Corporation
IART
|
940 M | $ 13.41 | -4.56 % | $ 1.03 B | ||
|
NuVasive
NUVA
|
86.1 M | - | - | $ 2.07 B | ||
|
Align Technology
ALGN
|
2.48 B | $ 165.15 | 0.78 % | $ 12.4 B | ||
|
Accuray Incorporated
ARAY
|
-519 M | $ 1.07 | -3.18 % | $ 110 M | ||
|
Avinger
AVGR
|
-421 M | - | -20.74 % | $ 369 K | ||
|
ClearPoint Neuro
CLPT
|
-191 M | $ 12.81 | -1.23 % | $ 346 M | ||
|
Orthofix Medical
OFIX
|
-276 M | $ 15.51 | -1.27 % | $ 591 M | ||
|
FONAR Corporation
FONR
|
-33.6 M | $ 14.86 | -0.03 % | $ 97.4 M | ||
|
AxoGen
AXGN
|
-291 M | $ 30.33 | 1.15 % | $ 1.34 B | ||
|
Axonics Modulation Technologies
AXNX
|
-374 M | - | - | $ 3.31 B | ||
|
GBS
GBS
|
-62.5 M | - | -0.57 % | $ 7.12 M | ||
|
CONMED Corporation
CNMD
|
560 M | $ 40.78 | 2.33 % | $ 1.26 B | ||
|
LENSAR
LNSR
|
-143 M | $ 11.48 | -0.17 % | $ 132 M |